Indefinite Delivery Contract SPE2D224D0008
Award Date
9/27/24
Last Date to Order
9/26/29
Federal Agency
Medical Supply Chain
Awardee
Specgx LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, a foreign-owned, for-profit pharmaceutical manufacturer. The $7.3 million contract is for the supply of oxycodone HCL-acetaminophen tablets in various strengths and package sizes to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. The...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) with a ceiling value of $6,939,222.50, awarded on July 15, 2019 to the prime contractor Specgx LLC, doing business as Mallinckrodt Pharmaceuticals. The contract was awarded by the Defense Logistics Agency, a component of the U.S. Department of Defense, to establish a national supply source for pharmaceutical products used by the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans...
This Federal Supply Schedule contract, awarded by the U.S. Department of Veterans Affairs (VA), provides Specgx LLC (doing business as Mallinckrodt Pharmaceuticals) a $107.6 million ceiling to deliver a variety of pharmaceutical products to federal agencies. Key items include methadone, buprenorphine, and other controlled substances used for pain management, substance abuse treatment, and medical research. Through this IDV, the VA and other agencies like the Department of Defense, Bureau of...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency, to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, a foreign-owned for-profit pharmaceutical manufacturer. The contract has a ceiling value of $29,250,715.90 and a period of performance extending to February 12, 2030. The contract aims to establish a national supply source for hydrocodone-acetaminophen tablets in various strengths and package sizes to support the DLA and...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) 36E79721D0013 to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, with a ceiling value of $28,220,287.65. The contract is for the supply of Buprenorphine HCL/Naloxone HCL Sublingual Tablets to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The period of performance is from June 7, 2021 to June 6, 2022, with four one-year option periods....
The federal contract IDV awarded to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, is a single-award Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,154,058.30 over five years, establishes Specgx LLC as the national supply source for Methylphenidate HCL Extended-Release Tablets in 10mg and 20mg strengths for the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs....
The U.S. Department of Veterans Affairs (VA) National Acquisition Center awarded a $1.388 million single-award Indefinite Delivery Contract (IDC) to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, for the supply of Atropine Sulfate/Diphenoxylate Hydrochloride tablets. The contract has a base period of one year from May 27, 2023 to May 26, 2024, with four one-year option periods, for a total potential performance period of 5 years. This IDC allows the VA, Department of Defense, Bureau...
The Indefinite Delivery Contract (IDC) SPE2D222D0147 was awarded by the Defense Logistics Agency (DLA) to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The single-award IDC has a total ceiling value of $10,967,220.00 and a period of performance running through September 13, 2027. Under this contract, Mylan will provide the DLA, Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service with a variety of...
The federal contract IDV award described is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valued at up to $499,999,999, runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health...
The federal contract IDV described is a Multiple Award Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer. The $11.8 million contract, running through August 2028, is for Schedule 65 IB pharmaceuticals, drugs, and hematology-related products, with a focus on naloxone products used to reverse opioid overdoses. Under this IDV, Emergent Devices has received numerous delivery orders from...